Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 31, 2017 16:05 ET | Source: Minerva Neurosciences, Inc.

Minerva Announces Amended Agreement for MIN-202 in Insomnia

Minerva to gain global strategic control over development of MIN-202 for insomnia Janssen cash payments to Minerva of up to $70 million, including $30 million upfront All shares in Minerva held by...